Sava raises $36m as glucose sensor deal takes shape
Ascensia partnership puts the London healthtech’s microsensor on the road to a European launch – with ambitions that run well beyond glucose. There is a neat irony in a fingerstick company funding the device that might make fingersticks unnecessary. Ascensia Diabetes Care, maker of the CONTOUR blood
<p>Ascensia partnership puts the London healthtech’s microsensor on the road to a European launch – with ambitions that run well beyond glucose. There is a neat irony in a fingerstick company funding the device that might make fingersticks unnecessary. Ascensia Diabetes Care, maker of the CONTOUR blood</p>